Given that HNSCC often arises in tissues with high exposure to pathogens, we postulated that TLR2 may modulate PDL1 expression following activation by PAMPs through enhanced NFκB signaling. The gene discussed is TLR2; the disease is head and neck squamous cell carcinoma.